StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) stock

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.86+0.16 (+5.98%)

Close on Nov 17, 2026Market cap $115.47MP/E –Yield –

Molecular Partners cash

Cash and short-term investments held at the end of each period.

Molecular Partners's cash was CHF 67.93M at Jun 30, 2026. For fiscal 2025 it was CHF 82.65M, up 29.4% from the year before. The highest annual figure on record is CHF 133.72M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 82.65M+29.4%
FY2024Dec 31, 2024CHF 63.87M-5.1%
FY2023Dec 31, 2023CHF 67.31M-23.5%
FY2022Dec 31, 2022CHF 87.95M+22.5%
FY2021Dec 31, 2021CHF 71.81M-46.3%
FY2020Dec 31, 2020CHF 133.72M+76.6%
FY2019Dec 31, 2019CHF 75.71M-23.5%
FY2018Dec 31, 2018CHF 98.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 67.93M+6.0%
Q4 FY2025Dec 31, 2025CHF 82.65M+22.8%
Q2 FY2025Jun 30, 2025CHF 81.98M+29.6%
Q4 FY2024Dec 31, 2024CHF 63.87M-27.4%
Q2 FY2024Jun 30, 2024CHF 64.06M-44.3%
Q4 FY2023Dec 31, 2023CHF 67.31M-6.3%
Q2 FY2023Jun 30, 2023CHF 63.24M-50.0%
Q4 FY2022Dec 31, 2022CHF 87.95M-34.2%
Q2 FY2022Jun 30, 2022CHF 114.94M+51.8%
Q4 FY2021Dec 31, 2021CHF 71.81M-27.4%
Q2 FY2021Jun 30, 2021CHF 126.57M–
Q4 FY2020Dec 31, 2020CHF 133.72M–
Q4 FY2019Dec 31, 2019CHF 75.71M–
Q4 FY2018Dec 31, 2018CHF 98.96M–

More Molecular Partners figures

See a number that looks wrong?